Fed. Circ. Upholds $20M Cialis Patent Verdict Against Lilly
The Federal Circuit on Wednesday upheld a $20 million verdict against Eli Lilly & Co. for infringing a German company's patent when marketing its erectile dysfunction drug Cialis to also treat...To view the full article, register now.
Already a subscriber? Click here to view full article